Mental health in patients with systemic sclerosis: A controlled investigation

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 3, 2008, Pages 336-340

  Mozzetta, Angelo ^a,b   Antinone, V ^a   Alfani, S ^a   Neri, P ^a   Bonda, P G Foglio ^a   Pasquini, P ^a   Puddu, P ^a   Picardi, A ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Anxiety; Depression; Self esteem; Systemic sclerosis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOMPERIDONE; ENALAPRIL; ILOPROST; NIFEDIPINE; PROTON PUMP INHIBITOR;

ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MELANOMA; MENTAL DISEASE; OUTPATIENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGICAL WELL BEING; PSYCHOSOCIAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; SELF ESTEEM; SELF REPORT; SYSTEMIC SCLEROSIS;

ADULT; ANXIETY; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HEALTH SURVEYS; HUMANS; MELANOMA; MENTAL HEALTH; MIDDLE AGED; NEVUS, PIGMENTED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SELF CONCEPT; SKIN NEOPLASMS;

EID: 39049127332     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02426.x     Document Type: Article

References (29)

1. Medsger TA Jr, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971; 74: 714-721.
2. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 1996; 22: 751-764.
3. Silman AJ. Scleroderma: Demographics and survival. J Rheumatol Suppl 1997; 48: 58-61.
4. Valentini G, Black C. Systemic sclerosis. Best Pract Res Clin Rheumatol 2002; 16: 807-816.
5. American Rheumatism Association. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
6. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
7. Silver RM. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 1991; 50: 854-861.
8. Senseman LA. Scleroderma associated with neurological and psychogenic symptoms: With four case reports. RI Med J 1957; 40: 684-685.
9. Gulledge AD. Scleroderma: Some psychiatric aspects of progressive systemic sclerosis. J Kans Med Soc 1968; 69: 593-596.
10. Moser DK, Clements PJ, Brecht ML, Weiner SR. Predictors of psychosocial adjustment in systemic sclerosis. The influence of formal education level, functional ability, hardiness, uncertainty, and social support. Arthritis Rheum 1993; 36: 1398-1405.
11. Malcarne VL, Greenbergs HL. Psychological adjustment to systemic sclerosis. Arthritis Care Res 1996; 9: 51-59.
12. Roca RP, Wigley FM, White B. Depressive symptoms associated with scleroderma. Arthritis Rheum 1996; 39: 1035-1040.
13. Straszecka J, Kucharz EJ, Jonderko G et al. Depression and anxiety in patients with systemic sclerosis. Clin Rheumatol 1996; 15: 621.
14. Merkel PA. Measurement of functional status, self-assessment, and psychological well-being in scleroderma. Curr Opin Rheumatol 1998; 10: 589-594.
15. Malcarne VL, Hansdottir I, Greenbergs HL et al. Appearance self-esteem in systemic sclerosis. Cognitive Ther Res 1999; 23: 197-208.
16. Angelopoulos NV, Drosos AA, Moutsopoulos HM. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 2001; 70: 145-150.
17. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ et al. The impact of pain and symptoms of depression in scleroderma. Pain 2002; 95: 267-275.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
19. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379.
20. Zung WW. A self-rating depression scale. Arch General Psychiatry 1965; 12: 63-70.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (DSM-IV). APA, Washington, DC, 1994.
22. Missiha SB, Solish N, From L. Characterizing anxiety in melanoma patients. J Cutan Med Surg 2003; 7: 443-448.
23. Al-Shakhli H, Harcourt D, Kenealy J. Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic. J Plast Reconstr Aesthet Surg 2006; 59: 479-486.
24. Cassileth BR, Lusk EJ, Tenaglia AN. A psychological comparison of patients with malignant melanoma and other dermatologic disorders. J Am Acad Dermatol 1982; 7: 742-746.
25. Trask PC, Paterson AG, Hayasaka S, Dunn RL, Riba M, Johnson T. Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol 2001; 19: 2844-2850.
26. Sampogna F, Picardi A, Chren MM et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004; 66: 620-624.
27. Staubach P, Eckhardt-Henn A, Dechene M et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006; 154: 294-298.
28. Renzi C, Picardi A, Abeni D et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Derm 2002; 138: 337-342.
29. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 2006; 54: 420-426.